Trial intelligence / Profile preview

Normal Oxygenation Maintenance in ICU

NCT01319643Phase 4Unknown

Sponsor
University of Modena and Reggio Emilia
Start
Dec 2009
Primary completion
Nov 2010
Modality
Inhalation Devices
Countries
1
01

Overview

Phase 4, randomised, open-label trial of oxygen in critical illness (2 arms), sponsored by University of Modena and Reggio Emilia. Primary endpoint: Mortality in Intensive Care Unit at 30 days. Status: unknown.

02

Drugs

oxygen
03

Conditions

critical illness

Beyond the preview

Go deeper on NCT01319643.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01319643.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call